The effect of urokinase in preventing the formation of epidural fibrosis and/or leptomeningeal arachnoiditis

Surgical Neurology

Volumn 47, Issue 2, 1997, Pages 124-127

  Ceviz, Adnan ^a,b   Arslan, Adem ^a   Ak, H Erdem ^a   Inalöz, Serap ^a  

^a DICLE UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Epidural fibrosis; spinal canal; urokinase

Indexed keywords

UROKINASE;

ADHESION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARACHNOIDITIS; ARTICLE; BLEEDING; CONTROLLED STUDY; FIBRINOLYSIS; FIBROSIS; MENINX; NONHUMAN; RAT; REOPERATION; SCAR FORMATION; SPINAL CORD; TISSUE REPAIR;

ADHESIONS; ANIMALS; ARACHNOIDITIS; DURA MATER; FIBROSIS; MENINGES; PLASMINOGEN ACTIVATORS; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031024151     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(96)00038-9     Document Type: Article

References (15)

1. Bundschuh CV, Modic MT, Ross JS, et al. Epidural fibrosis and recurrent disk herniation in the lumbar spine: MR imaging assessment. Am Journal Roentgenology 1988;150:923-32.
2. Dolan RA. Spinal adhesive arachnoiditis. Surg Neurol 1993;39:479-84.
3. Findlay JM, Weir BKA, Kassell NF, et al. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75:181-8.
4. Findlay JM, Weir BKA, Steinke D, et al. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in aprimate model of SAH. J Neurosurg 1988;69:723-35.
5. Fodstad H, Kok P, Algers G. Fibrinolytic activity of cerebral tissue after experimental subarachnoid hemorrhage: inhibitory effect of tranexamic acid (AMCA). Acta Neurol Scand 1981;64:29-46.
6. Guyer DW, Wiltse LL, Eskay ML, Guyer BH. The long range prognosis of arachnoiditis. Spine 1989;14:1332-41.
7. Julow J. Prevention of subarachnoid fibrosis after subarachnoid haemorrhage with urokinase: scanning electron microscopic study in the dog. Acta-Neurochir-Wien 1979;51(1-2):51-63.
8. Kassell NF, Torner JC, Adams HP. Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. J Neurosurg 1984;61:225-30.
9. Kwaan HC, Astrup T. Fibrinolytic activity of reparative connective tissue. BJ Pathol 1964;87:409-14.
10. Langenskiold A, and Kiviluoto O. Prevention of epidural scar formation after operations on the lumbar spine by means of fat transplantation. Clin Orthop 1976;115:92-5.
11. La Rocca H, and Macnab J. The laminectomy membrane. Studies in its evolution, characteristics, effect and prophylaxis in dogs. J Bone Joint Surg 1974;56B: 545-50.
12. Mohadjer M, Anagnastopoulos J, Eggert HR, et al. The effect of urokinase on the central nervous system. Animal experimental study. Haemostasis 1988;18 (Suppl 2):81.
13. Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model: part 2, in vivo safety study of intraventricular urokinase. Neurosurgery 1986;19:547-52.
14. Porter JM, Acinapura AJ, Kapp JP, et al. Fibrinolytic activity of the spinal fluid and meninges. Surg Forum 1966;17:425-27.
15. Reigel DH, Bazmi B, Shih SR, Marquardt MD. A pilot investigation of Poloxamer 407 for the prevention of leptomeningeal adhesions in the rabbit. Pediatr Neurosurg 1993;19:250-5.